Weighted average period over which cost is expected to be recognized (in years)

  
The terms of the DXC Director Equity Plan allow DXC to grant RSU awards to non-employee directors of DXC. Such RSU awards vest in full at the earlier of (i) the first anniversary of the grant date or (ii) the next annual meeting date, and are automatically redeemed for DXC common stock and dividend equivalents either at that time or, if an RSU deferral election form is submitted, upon the date or event elected by the director. Distributions made upon a director’s separation from the Board may occur in either a lump sum or in annual installments over periods of 5, 10, or 15 years, per the director’s election. In addition, RSUs vest in full upon a change in control of DXC.  
The DXC Share Purchase Plan allows DXC’s employees located in the U.K. to purchase shares of DXC’s common stock at the fair market value of such shares on the applicable purchase date. There were 29,391 shares purchased under this plan during fiscal 2022.  
The Board has reserved for issuance shares of DXC common stock, par value $0.01 per share, under each of the plans as detailed below:

|  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
|  |  |  |  |  |  |  |  |  |  |  |  |
|  | As of March 31, 2022 |
|  | Reserved for issuance |  | Available for future grants |
| DXC Employee Equity Plan | 51,200,000  |  |  | 31,331,818  |  |
| DXC Director Equity Plan | 745,000  |  |  | 361,651  |  |
| DXC Share Purchase Plan | 250,000  |  |  | 125,917  |  |
| Total | 52,195,000  |  |  | 31,819,386  |  |

  
The Company recognized share-based compensation expense for fiscal 2022, 2021 and 2020 as follows:

|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
|  |  | Fiscal Years Ended |
| (in millions) |  | March 31, 2022 |  | March 31, 2021 |  | March 31, 2020 |
|  |  |  |  |  |  |  |
|  |  |  |  |  |  |  |
| Total share-based compensation cost |  | $ | 101  |  |  | $ | 56  |  |  | $ | 68  |  |
| Related income tax benefit |  | $ | 14  |  |  | $ | 6  |  |  | $ | 12  |  |
| Total intrinsic value of options exercised |  | $ | 8  |  |  | $ | 1  |  |  | $ | 8  |  |
| Tax benefits from exercised stock options and awards |  | $ | 17  |  |  | $ | 6  |  |  | $ | 14  |  |
|  |  |  |  |  |  |  |

  
As of March 31, 2022, total unrecognized compensation expense related to unvested DXC RSUs, net of expected forfeitures was $151 million, respectively. The unrecognized compensation expense for unvested RSUs is expected to be recognized over a weighted-average period of 1.79 years.117
